RVRobert K. Vincent

Robert K. Vincent

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Robert K. Vincent has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Jon Odorico

    Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792; William S. Middleton Memorial Veterans Administration Hospital, Madison, WI 53705; WiCell Research Institute, Madison, WI 53707

    1 shared publication
  • Jon Scott Odorico

    Division of Transplantation, Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI

    1 shared publication
  • Joseph F. Magliocca

    University of Wisconsin‐Madison School of Medicine and Public Health, Department of Surgery, Madison, Wisconsin, USA

    1 shared publication
  • Melisa Budde

    Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792; William S. Middleton Memorial Veterans Administration Hospital, Madison, WI 53705; WiCell Research Institute, Madison, WI 53707

    1 shared publication
  • Melisa L. Budde

    University of Wisconsin‐Madison School of Medicine and Public Health, Department of Surgery, Madison, Wisconsin, USA

    1 shared publication
  • Nathan R. Treff

    University of Wisconsin-Madison School of Medicine and Public Health, Department of Surgery, Madison, Wisconsin, USA

    1 shared publication

Latest Publications

  • Generation and Characterization of Novel Tetracycline-Inducible Pancreatic Transcription Factor-Expressing Murine Embryonic Stem Cell Lines

    by Robert Vincent, Nathan Treff, Melisa Budde, Zachary Kastenberg, Jon Odorico

    Pancreatic development in mammals is controlled in part by the expression and function of numerous genes encoding transcription factors. Yet, how these regulate each other and their target genes is incompletely understood. Embryonic stem (ES) cells have recently been shown to be capable of differentiating into pancreatic progenitor cells and insulin-producing cells, representing a useful in vitro model system for studying pancreatic and islet development. To generate tools to study the relationships of transcription factors in pancreatic development we have established seven unique mouse ES cell lines with tetracycline-inducible expression of either Hnf4α, Hnf6, Nkx2.2, Nkx6.1, Pax4, Pdx1, and Ptf1a cDNAs. Each of the cell lines was characterized for induction of transgene expression after exposure to doxycycline (DOX) by quantitative real-time PCR and immunofluorescence microscopy. Transgene expression in the presence of DOX was at least 97-fold that seen in untreated cells. Immunofluorescent staining of DOX-treated cultures showed efficient (>95% of cells) transgene protein expression while showing β cells from ES cells.


  • Differentiation of Embryonic Stem Cells Conditionally Expressing Neurogenin 3

    by Nathan R. Treff, Robert K. Vincent, Melisa L. Budde, Victoria L. Browning, Joseph F. Magliocca, Vivek Kapur, Jon S. Odorico

    Expression of the proendocrine gene neurogenin 3 (Ngn3) is required for the development of pancreatic islets. To better characterize the molecular events regulated by Ngn3 during development, we have determined the expression profiles of murine embryonic stem cells (mESCs) uniformly induced to overexpress Ngn3. An mESC line was created in order to induce Ngn3 by adding doxycycline to the culture medium. Genome-wide microarray analysis was performed to identify genes regulated by Ngn3 in a variety of contexts, including undifferentiated ESCs and differentiating embryoid bodies (EBs). Genes regulated by Ngn3 in a context-independent manner were identified and analyzed using systematic gene ontology tools. This analysis revealed Notch signaling as the most significantly regulated signaling pathway (p = .009). This result is consistent with the hypothesis that Ngn3 expression makes the cell competent for Notch signaling to be activated and, conversely, more sensitive to Notch signaling inhibition. Indeed, EBs induced to express Ngn3 were significantly more sensitive to gamma-secretase inhibitor-mediated Notch signaling inhibition (p < .0001) when compared with uninduced EBs. Moreover, we find that Ngn3 induction in differentiating ESCs results in significant increases in insulin, glucagon, and somatostatin expression.